A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Methods for simple, rapid induction of a back pain model in mice are provided here using an intraligament injection of urinary plasminogen activator.
A model of persisting lower back pain can be induced in mice with the simple methodology described herein. Step-by-step methods for simple, rapid induction of a persisting back pain model in mice are provided here using an injection of urokinase-type plasminogen activator (urokinase), a serine protease present in humans and other animals. The methodology for induction of persisting lower back pain in mice involves a simple injection of urokinase along the ligamentous insertion region of the lumbar spine. The urokinase inflammatory agent activates plasminogen to plasmin. Typically, the model can be induced within 10 min and hypersensitivity persists for at least 8 weeks.
Hypersensitivity, gait disturbance, and other standard anxiety- and depression-like measures can be tested in the persisting model. Back pain is the most prevalent type of pain. To improve awareness of back pain, the International Association for the Study of Pain (IASP) named 2021 the "Global Year about Back Pain" and 2022 the "Global Year for Translating Pain Knowledge to Practice." One limitation of the therapeutic advancement of pain therapeutics is the lack of suitable models for testing persistent and chronic pain. The features of this model are suitable for testing potential therapeutics aimed at the reduction of back pain and its ancillary characteristics, contributing to IASP's naming 2022 as the Global Year for Translating Pain Knowledge to Practice.
Low back pain is one of the most common causes of disability with 1 in 5 people suffering worldwide1. In spite of these efforts, few reliable animal models of back pain are popularly used in animal research in the pain field, especially in mice. Previous models have almost exclusively made use of rats for the induction of chronic back pain (CBP) such as those induced by injection of urinary plasminogen activator (uPA) into the lumbar facet joint2,3, injection of nerve growth factor (NGF) into trunk musculature4, or monosodium iodoacetate (MIA)5 or interleukin-1beta6 injection in the intravertebral disc. Of course, rats are preferred for these models mainly due to their larger size and ease of access for injection of inflammatory agents.
To be clear, mouse models of back pain do exist such as the SPARC-null mouse model of intervertebral-disc degeneration used for many years7, but these are more costly and time-consuming to establish than injection-based models. A recent mouse study established a model of lower back pain by combining NGF injection into low back muscles with vertical chronic restraint stress8. In the following protocol, we have adapted the uPA-induced CBP model from rats for mice2. Hypersensitivity is established within 1 week and persists up to 6-8 weeks. In addition, we establish that mice develop anxiety- and depression-like behaviors. Given the prevalence of back pain and the more common use of mice in molecular pain research, this durable model is readily established for use in the development of new treatment strategies for back pain relief.
All animal procedures described are in compliance with the NIH Guide for the Care and Use of Laboratory Animals. Studies were approved by the local Institutional Care and Use Committee (IACUC #23-201364-HSC) of the University of New Mexico Health Sciences Center. All studies comply with policies under the auspices of an OLAW Assurance of Compliance (A3002-01) on the use of animals in research, as described in Part III. II. Assurances and Certifications. Animals are housed in the Animal Resources Center (ARC) housing facility maintained by the laboratory staff and Division of Laboratory and Animal Resources (DLAR) staff. The method of euthanasia (100 µL of 59 mg/mL pentobarbital injection) is rapid and reliable and allows for the dissection and collection of various tissues for further research.
1. Animals
2. Model induction
Figure 1: Setup for urokinase CBP induction. (A) The Fine Science Tools baseplate recommended for mouse surgeries. The ribbed edges can have hooked string on them for holding the mouse in place. (B) Recovery station. An empty housing cage is recommended, half on the heating pad, half off. A clean cloth is placed on the bottom to give the mouse a comfortable resting area. (C) Anesthesia machine setup recommendation. Using a two-channel delivery system, set up one hose to the induction chamber and another to the surgery station. (D) A view of the mouse restraints. Two strings are knotted onto the ribbed edges of the base plate, then gently pulled across the mouse's neck and rear respectively. Make sure not to restrain the mouse too tightly so that it can still breathe normally. Please click here to view a larger version of this figure.
Figure 2: Urokinase injection induction of CBP. (A) A view of the injection site placement. As shown, feel with fingers to find the bottom of the mouse's ribcage for a reference point for L4-L5. (B) A view of the injection process, showing the angle for proper injection. (C) A 45° angle is preferable here, but adjust as needed to ensure the needle gets where it needs to. If needed, shave the injection site for better visualization. Please click here to view a larger version of this figure.
Figure 3: Diagram of the injection site. (A) A photograph of the location of the injection site. Ink is used here to indicate where the liquid will be entering the interspinous ligament between the L2 and L3 vertebrae. (B) A diagram showing the proper positioning of the needle and location of the injection site, shown from a side view. (C) A diagram showing a top-down view of the vertebrae, and injection sites for the interspinous ligaments. Injections will typically be on the interspinous ligaments next to the spine, but the needle can be inserted in the space between and intertransverse vertebrae as well. The use of blue dye in pilot trials is recommended as shown in (A). Please click here to view a larger version of this figure.
3. Behavioral assays
Figure 4: Mechanical and thermal hypersensitivity following CBP induction. Pain is measurable a week following model induction and persists for 8 weeks. (A) von Frey test. Mechanical threshold testing is performed with von Frey filaments applied to the footpad through a mesh top table with the up-down method as shown here over the course of 4 weeks. The naïve male threshold (green) is hidden beneath the blue line for the naïve female mice. The CBP mice (n = 4 males, 4 females) showed significantly increased mechanical sensitivity compared to the naïve controls (n = 2 males, 2 females). Two-way ANOVA (Dunnett's multiple comparisons test) was performed on these data: n = 4 per group. In post-hoc analyses, Bonferroni adjustment to all P-values for week-by-week comparisons of CBP versus Naïve yielded all 11 values < 0.0011. **** p < 0.0001. (B) Hargreaves test. The heat threshold was tested on the footpad with the Hargreaves test (50 °C). The CBP mice (n = 12 males, 12 females) showed significantly increased heat sensitivity compared to the naïve controls (n = 6 males, 6 females). Mann-Whitney two-tailed t-test was performed to test significance (p < 0.0001). (C) Cold sensitivity. The cold probe test was performed by placing mice on the cold plate apparatus cooled to -9 °C. Latency to withdraw was recorded as the time in seconds from placement of the mouse on the apparatus until the mouse begins foot lifting, licking, or shaking. In the data shown, a cold probe cooled to -9 °C was placed underneath the mouse's hind paw while the mouse is caged on top of a wire mesh. All mice were tested 1-3 weeks post injection. The CBP mice (n = 4 males, 6 females) showed significantly increased cold sensitivity compared to the naïve controls (n = 2 males, 4 females). Mann-Whitney two-tailed t-test was performed to test significance (p = 0.0002). Please click here to view a larger version of this figure.
Nociceptive-related behavioral testing and data analysis
Evoked measures
Hypersensitivity on the footpad develops within a day of urokinase injection. Within 1 week, the withdrawal threshold is significantly decreased and persists until euthanasia; this is shown through postsurgical week 4 (Figure 4A). Paw withdrawal latency is analyzed using the von Frey up-down method9 and the Hargreaves test. In the example plotted, mic...
This model of chronic back pain is simple to induce, and hypersensitivity established within 1 week can last for up to (and possibly beyond) 8 weeks. This allows for accurate study of the chronic pain state as opposed to other acute models that only last for a week or two. While we show the model in mice, the uPA-induced CBP model can also be established in rats2. An advantage of the model is that the prolonged time course provokes the development of anxiety- and depression-like behaviors, which a...
The authors declare no competing financial interests. KNW acknowledges unpaid consultation with NeuroChronix, Bessor Pharma, and USA Elixeria BioPharm, Inc.
Grant funding was provided by NIH HEAL UG3 NS123958. The housing facilities were inspected and accredited by AAALAC. Animals were housed in the Animal Resources Center (ARC) housing facility maintained by the laboratory staff and Division of Laboratory and Animal Resources (DLAR) staff. The procedures for behavioral testing are standard methods in the field as approved by the American Pain Society and the International Association for the Study of Pain. The method of euthanasia is consistent with recommendations of the Panel on Euthanasia of the American Veterinary Medical Association.
Name | Company | Catalog Number | Comments |
Animals and Consumables | |||
70% ethanol | Local Source | ||
BALB/c mice | Envigo | 20-25 g | |
Cotton balls | Fisher Scientific | 19-090-702 | |
Cotton-tipped applicators | Fisher Scientific | 19-062-616 | |
Isoflurane inhalant anesthetic | MedVet | RXISO-250 | |
Labeling tape | Fisher Scientific | NGFP7002 | |
Nitrile exam gloves | Fisher Scientific | ||
Oxygen tank | Local Source | ||
Surgical drape, Steri-Drape Utility Sheet, Absorbent Prevention | VWR | 76246-788 | cut into 15 x 15 cm pieces |
Tygon tubing with 3 mm inner diameter | Grainger | 22XH87 | |
Equipment | |||
#11 carbon steel scalpel blades | VWR | 21909-612 | |
Anesthesia induction chamber | Summit Medical Equipment Company | AS-01-0530-LG | |
Autoclave | Local Unit | ||
Biology Dumont #5 forceps | Fine Science Tools | 11252-30 | |
Glass bead sterilizer Germinator 500 | VWR | 102095-946 | |
IITC Life Sciences Series 8 Model PE34 Hot/Cold Plate Analgesia Meter | IITC | PE34 | |
Integra Miltex cotton & dressing pliers | Safco Dental Supply | 66-317 | |
OPTIKA CL31 double arm LED illuminator | New York Microscope Company | OPCL-31 | |
Plantar Test System with InfraRed Emitter, i. e. Hargreaves Apparatus | Ugo Basile | 37370-001 and 37370-002 | |
Scalpel Handle No. 3 | VWR | 25607-947 | |
Small animal heating pad | Valley Vet Supply | 47375 | |
Student Vannas spring scissors, straight blade | Fine Science Tools | 91500-09 | |
Table top animal research portable anesthesia workstation “PAM” | Patterson Scientific | AS-01-0007 | |
Von Frey Filaments | Ugo Basile | 37450-275 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved